Dr. Mark Andermann

Mark Andermann, Ph.D., opened his laboratory in the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess Medical Center (BIDMC) in 2012.  He is a faculty member of the Harvard PhD Program in Neuroscience and Ph.D. Program in Biophysics and a Professor of Medicine and Neurobiology at Harvard Medical School. Dr. Andermann graduated from McGill University in 1999 with a joint honors degree in mathematics and physics, and received his Ph.D. in biophysics and neuroscience in 2005 from Harvard University. Dr. Andermann completed his postdoctoral training with Dr. Clay Reid at Harvard Medical School, where he developed new tools for studying the neural basis of visual perception and attention, by tracking neural activity in the same individual brain cells across months in behaving mice.  His lab seeks to understand how the needs of the body bias learning, attention, and imagery towards need-relevant objects. To achieve these goals, the lab employs cellular and subcellular imaging of brain cells in retina, thalamus, cortex, amygdala, hypothalamus, brainstem and choroid plexus across weeks as mice seek food, water, mates, or safety. Current efforts include efforts geared towards therapies targeted to brain cell types that regulate obesity, binge eating, and other eating disorders. This work has been supported, in part, by a Pew Scholars Award in the Biomedical Sciences, a Smith Family Foundation Award for Excellence in Medical Research, a McKnight Scholar Award, and a Director’s New Innovator Award and Pioneer Award from the National Institutes of Health.